A unique case series of novel biomarkers of cardiac damage in cyclists completing the 4800 km Race Across America (RAAM)

K. Williams, K. George, A. Hulton, R. Godfrey, I. Lahart, M. G. Wilson, S. Charlesworth, D. Warburton, D. Gaze, G. Whyte

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Prolonged strenuous exercise is associated with the appearance of biomarkers of cardiac cell damage and a decline in cardiac function during recovery. Few studies have assessed repeated bouts of prolonged exercise and whether this results in further biomarker accumulation and greater dysfunction. Further, it may be useful to describe the changes in a range of biomarkers that may provide additional insight into the clinical significance of cardiac biomarker release. Four highly trained cyclists completed the 4800 km Race Across America (RAAM) in 7 days. Venous blood samples and echocardiograms were taken prior to, every 24 hours during and immediately after the RAAM. Venous blood was analysed for cardiac troponin I (cTnI), creatine kinase MB (CK-MB), fatty acid binding protein (HFABP), glycogen phosphorylase BB (GPBB) and N-Terminal Brain Natriuretic Peptide (NTproBNP). Echocardiograms allowed analysis of septal, left ventricular free wall and right ventricular free wall tissue velocities during systole and diastole. Before the RAAM cTnI levels were below the assay detection level (0.02 ng.ml -1). In three riders cTnI peaked on day one (0.03 ng.ml -1) and returned below detection levels post race. In the 4 th rider cTnI peaked on day 5 (0.08 ng.ml -1) and was still elevated post-race. Both CK-MB and H-FABP were increased during the RAAM in all 4 cyclists. In three riders H-FABP peaked on day one (3.49 to 5.09 ng.ml -1) and declined over the rest of the RAAM. In the final rider H-FABP peaked on day two (5.90 ng.ml -1) and then dropped back to baseline by the post-RAAM assessment. Interestingly, changes in H-FABP mirrored, temporally, changes in CK-MB in places and this may reflect an association with skeletal muscle damage. Data for GPBB value to (2.9 - 149.6 ng.ml -1) and NTproBNP value to (27.3 - 310.0 ng.L -1) were variable but again was elevated in all riders during the course of the RAAM. Changes in ventricular wall tissue velocities were minor and not cumulative. Peak atrial diastolic tissue velocity in the left ventricular free wall increased (P < 0.05) from 11 to 18 cm.s -1 over the last two race days but this did not significantly impact the ratio of early to late diastolic wall motion. Cardiac biomarkers were elevated during the completion of the RAAM in all 4 cyclist but changes were not cumulative which suggest that the hearts of the cyclists coped well with the extreme cardiac work demanded by this ultra-endurance exercise challenge.

Original languageEnglish
Pages (from-to)3446-3451
Number of pages6
JournalCurrent Medicinal Chemistry
Volume18
Issue number23
DOIs
Publication statusPublished - Aug 2011
Externally publishedYes

Fingerprint

Biomarkers
Troponin I
MB Form Creatine Kinase
Glycogen Phosphorylase
Exercise
Fatty Acid-Binding Proteins
Diastole
Systole
Brain Natriuretic Peptide
Recovery of Function
Skeletal Muscle

Cite this

Williams, K. ; George, K. ; Hulton, A. ; Godfrey, R. ; Lahart, I. ; Wilson, M. G. ; Charlesworth, S. ; Warburton, D. ; Gaze, D. ; Whyte, G. / A unique case series of novel biomarkers of cardiac damage in cyclists completing the 4800 km Race Across America (RAAM). In: Current Medicinal Chemistry. 2011 ; Vol. 18, No. 23. pp. 3446-3451.
@article{066c67dd799a4af78906908dcde7a851,
title = "A unique case series of novel biomarkers of cardiac damage in cyclists completing the 4800 km Race Across America (RAAM)",
abstract = "Prolonged strenuous exercise is associated with the appearance of biomarkers of cardiac cell damage and a decline in cardiac function during recovery. Few studies have assessed repeated bouts of prolonged exercise and whether this results in further biomarker accumulation and greater dysfunction. Further, it may be useful to describe the changes in a range of biomarkers that may provide additional insight into the clinical significance of cardiac biomarker release. Four highly trained cyclists completed the 4800 km Race Across America (RAAM) in 7 days. Venous blood samples and echocardiograms were taken prior to, every 24 hours during and immediately after the RAAM. Venous blood was analysed for cardiac troponin I (cTnI), creatine kinase MB (CK-MB), fatty acid binding protein (HFABP), glycogen phosphorylase BB (GPBB) and N-Terminal Brain Natriuretic Peptide (NTproBNP). Echocardiograms allowed analysis of septal, left ventricular free wall and right ventricular free wall tissue velocities during systole and diastole. Before the RAAM cTnI levels were below the assay detection level (0.02 ng.ml -1). In three riders cTnI peaked on day one (0.03 ng.ml -1) and returned below detection levels post race. In the 4 th rider cTnI peaked on day 5 (0.08 ng.ml -1) and was still elevated post-race. Both CK-MB and H-FABP were increased during the RAAM in all 4 cyclists. In three riders H-FABP peaked on day one (3.49 to 5.09 ng.ml -1) and declined over the rest of the RAAM. In the final rider H-FABP peaked on day two (5.90 ng.ml -1) and then dropped back to baseline by the post-RAAM assessment. Interestingly, changes in H-FABP mirrored, temporally, changes in CK-MB in places and this may reflect an association with skeletal muscle damage. Data for GPBB value to (2.9 - 149.6 ng.ml -1) and NTproBNP value to (27.3 - 310.0 ng.L -1) were variable but again was elevated in all riders during the course of the RAAM. Changes in ventricular wall tissue velocities were minor and not cumulative. Peak atrial diastolic tissue velocity in the left ventricular free wall increased (P < 0.05) from 11 to 18 cm.s -1 over the last two race days but this did not significantly impact the ratio of early to late diastolic wall motion. Cardiac biomarkers were elevated during the completion of the RAAM in all 4 cyclist but changes were not cumulative which suggest that the hearts of the cyclists coped well with the extreme cardiac work demanded by this ultra-endurance exercise challenge.",
keywords = "Biomarkers, Echocardiogram, Exercise induced cardiac damage, Prolonged exercise, TDI",
author = "K. Williams and K. George and A. Hulton and R. Godfrey and I. Lahart and Wilson, {M. G.} and S. Charlesworth and D. Warburton and D. Gaze and G. Whyte",
year = "2011",
month = "8",
doi = "10.2174/092986711796642616",
language = "English",
volume = "18",
pages = "3446--3451",
journal = "Current Medicinal Chemistry",
issn = "0929-8673",
publisher = "Bentham Science Publishers B.V.",
number = "23",

}

Williams, K, George, K, Hulton, A, Godfrey, R, Lahart, I, Wilson, MG, Charlesworth, S, Warburton, D, Gaze, D & Whyte, G 2011, 'A unique case series of novel biomarkers of cardiac damage in cyclists completing the 4800 km Race Across America (RAAM)', Current Medicinal Chemistry, vol. 18, no. 23, pp. 3446-3451. https://doi.org/10.2174/092986711796642616

A unique case series of novel biomarkers of cardiac damage in cyclists completing the 4800 km Race Across America (RAAM). / Williams, K.; George, K.; Hulton, A.; Godfrey, R.; Lahart, I.; Wilson, M. G.; Charlesworth, S.; Warburton, D.; Gaze, D.; Whyte, G.

In: Current Medicinal Chemistry, Vol. 18, No. 23, 08.2011, p. 3446-3451.

Research output: Contribution to journalArticle

TY - JOUR

T1 - A unique case series of novel biomarkers of cardiac damage in cyclists completing the 4800 km Race Across America (RAAM)

AU - Williams, K.

AU - George, K.

AU - Hulton, A.

AU - Godfrey, R.

AU - Lahart, I.

AU - Wilson, M. G.

AU - Charlesworth, S.

AU - Warburton, D.

AU - Gaze, D.

AU - Whyte, G.

PY - 2011/8

Y1 - 2011/8

N2 - Prolonged strenuous exercise is associated with the appearance of biomarkers of cardiac cell damage and a decline in cardiac function during recovery. Few studies have assessed repeated bouts of prolonged exercise and whether this results in further biomarker accumulation and greater dysfunction. Further, it may be useful to describe the changes in a range of biomarkers that may provide additional insight into the clinical significance of cardiac biomarker release. Four highly trained cyclists completed the 4800 km Race Across America (RAAM) in 7 days. Venous blood samples and echocardiograms were taken prior to, every 24 hours during and immediately after the RAAM. Venous blood was analysed for cardiac troponin I (cTnI), creatine kinase MB (CK-MB), fatty acid binding protein (HFABP), glycogen phosphorylase BB (GPBB) and N-Terminal Brain Natriuretic Peptide (NTproBNP). Echocardiograms allowed analysis of septal, left ventricular free wall and right ventricular free wall tissue velocities during systole and diastole. Before the RAAM cTnI levels were below the assay detection level (0.02 ng.ml -1). In three riders cTnI peaked on day one (0.03 ng.ml -1) and returned below detection levels post race. In the 4 th rider cTnI peaked on day 5 (0.08 ng.ml -1) and was still elevated post-race. Both CK-MB and H-FABP were increased during the RAAM in all 4 cyclists. In three riders H-FABP peaked on day one (3.49 to 5.09 ng.ml -1) and declined over the rest of the RAAM. In the final rider H-FABP peaked on day two (5.90 ng.ml -1) and then dropped back to baseline by the post-RAAM assessment. Interestingly, changes in H-FABP mirrored, temporally, changes in CK-MB in places and this may reflect an association with skeletal muscle damage. Data for GPBB value to (2.9 - 149.6 ng.ml -1) and NTproBNP value to (27.3 - 310.0 ng.L -1) were variable but again was elevated in all riders during the course of the RAAM. Changes in ventricular wall tissue velocities were minor and not cumulative. Peak atrial diastolic tissue velocity in the left ventricular free wall increased (P < 0.05) from 11 to 18 cm.s -1 over the last two race days but this did not significantly impact the ratio of early to late diastolic wall motion. Cardiac biomarkers were elevated during the completion of the RAAM in all 4 cyclist but changes were not cumulative which suggest that the hearts of the cyclists coped well with the extreme cardiac work demanded by this ultra-endurance exercise challenge.

AB - Prolonged strenuous exercise is associated with the appearance of biomarkers of cardiac cell damage and a decline in cardiac function during recovery. Few studies have assessed repeated bouts of prolonged exercise and whether this results in further biomarker accumulation and greater dysfunction. Further, it may be useful to describe the changes in a range of biomarkers that may provide additional insight into the clinical significance of cardiac biomarker release. Four highly trained cyclists completed the 4800 km Race Across America (RAAM) in 7 days. Venous blood samples and echocardiograms were taken prior to, every 24 hours during and immediately after the RAAM. Venous blood was analysed for cardiac troponin I (cTnI), creatine kinase MB (CK-MB), fatty acid binding protein (HFABP), glycogen phosphorylase BB (GPBB) and N-Terminal Brain Natriuretic Peptide (NTproBNP). Echocardiograms allowed analysis of septal, left ventricular free wall and right ventricular free wall tissue velocities during systole and diastole. Before the RAAM cTnI levels were below the assay detection level (0.02 ng.ml -1). In three riders cTnI peaked on day one (0.03 ng.ml -1) and returned below detection levels post race. In the 4 th rider cTnI peaked on day 5 (0.08 ng.ml -1) and was still elevated post-race. Both CK-MB and H-FABP were increased during the RAAM in all 4 cyclists. In three riders H-FABP peaked on day one (3.49 to 5.09 ng.ml -1) and declined over the rest of the RAAM. In the final rider H-FABP peaked on day two (5.90 ng.ml -1) and then dropped back to baseline by the post-RAAM assessment. Interestingly, changes in H-FABP mirrored, temporally, changes in CK-MB in places and this may reflect an association with skeletal muscle damage. Data for GPBB value to (2.9 - 149.6 ng.ml -1) and NTproBNP value to (27.3 - 310.0 ng.L -1) were variable but again was elevated in all riders during the course of the RAAM. Changes in ventricular wall tissue velocities were minor and not cumulative. Peak atrial diastolic tissue velocity in the left ventricular free wall increased (P < 0.05) from 11 to 18 cm.s -1 over the last two race days but this did not significantly impact the ratio of early to late diastolic wall motion. Cardiac biomarkers were elevated during the completion of the RAAM in all 4 cyclist but changes were not cumulative which suggest that the hearts of the cyclists coped well with the extreme cardiac work demanded by this ultra-endurance exercise challenge.

KW - Biomarkers

KW - Echocardiogram

KW - Exercise induced cardiac damage

KW - Prolonged exercise

KW - TDI

UR - http://www.scopus.com/inward/record.url?scp=80051999958&partnerID=8YFLogxK

U2 - 10.2174/092986711796642616

DO - 10.2174/092986711796642616

M3 - Article

VL - 18

SP - 3446

EP - 3451

JO - Current Medicinal Chemistry

JF - Current Medicinal Chemistry

SN - 0929-8673

IS - 23

ER -